Open Access
Treatment Approaches for First Episode and Early-Phase Schizophrenia in Adolescents and Young Adults: A Delphi Consensus Report from Europe
Author(s) -
Christoph U. Correll,
Paolo FusarPoli,
Stefan Leucht,
Anne Karow,
Nadja P. Maric,
Carmen Moreno,
Merete Nordentoft,
Andrea Raballo
Publication year - 2022
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s345066
Subject(s) - medicine , delphi method , pharmacovigilance , psychiatry , schizophrenia (object oriented programming) , standardization , dosing , delphi , adverse effect , family medicine , pediatrics , drug , pharmacology , statistics , mathematics , political science , computer science , law , operating system
Although first-episode psychosis (FEP) in youth, particularly early-onset schizophrenia (EOS), is managed similarly to adult-onset schizophrenia, few antipsychotics are approved for people aged 13-18 years. We aimed to explore areas of uncertainty in EOS management and provide evidence-based recommendations to mental health specialists. We used the Delphi methodology to gain knowledge in areas lacking evidence-based strategies. This standardized methodology consists of the development of a questionnaire by content experts, which is then submitted to a broader panel of professionals (panelists) to survey their level of agreement on the topics proposed.